Cellergy is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Ratis, Llc. The primary component is Calcium Fluoride; Calcium Sulfate Anhydrous; Dibasic Potassium Phosphate; Ferrosoferric Phosphate; Magnesium Phosphate, Dibasic Trihydrate; Potassium Chloride; Potassium Sulfate; Silicon Dioxide; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate; Sodium Sulfate; Tribasic Calcium Phosphate.
Product ID | 71753-8099_5f471122-6961-4be6-bfce-20cae3e45475 |
NDC | 71753-8099 |
Product Type | Human Otc Drug |
Proprietary Name | Cellergy |
Generic Name | Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Ferrum Phosphoricum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Magnesia Phosphorica, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Silicea. |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2019-10-08 |
Marketing End Date | 2025-12-01 |
Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
Labeler Name | Ratis, LLC |
Substance Name | CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE |
Active Ingredient Strength | 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharm Classes | Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
NDC Exclude Flag | N |
Marketing Start Date | 2019-10-08 |
Marketing End Date | 2025-12-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved homeopathic |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-10-08 |
Ingredient | Strength |
---|---|
CALCIUM FLUORIDE | 12 [hp_X]/mL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CELLERGY 98303056 not registered Live/Pending |
Cellergy Therapeutics, Inc. 2023-12-07 |
CELLERGY 78219251 not registered Dead/Abandoned |
Superior Associates, Inc. 2003-02-26 |